These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 33909465)

  • 81. Preoperative prediction of lymphovascular invasion in invasive breast cancer with dynamic contrast-enhanced-MRI-based radiomics.
    Liu Z; Feng B; Li C; Chen Y; Chen Q; Li X; Guan J; Chen X; Cui E; Li R; Li Z; Long W
    J Magn Reson Imaging; 2019 Sep; 50(3):847-857. PubMed ID: 30773770
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Artificial Intelligence-Based Classification of Breast Lesions Imaged With a Multiparametric Breast MRI Protocol With Ultrafast DCE-MRI, T2, and DWI.
    Dalmiş MU; Gubern-Mérida A; Vreemann S; Bult P; Karssemeijer N; Mann R; Teuwen J
    Invest Radiol; 2019 Jun; 54(6):325-332. PubMed ID: 30652985
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Breast MRI contrast enhancement kinetics of normal parenchyma correlate with presence of breast cancer.
    Wu S; Berg WA; Zuley ML; Kurland BF; Jankowitz RC; Nishikawa R; Gur D; Sumkin JH
    Breast Cancer Res; 2016 Jul; 18(1):76. PubMed ID: 27449059
    [TBL] [Abstract][Full Text] [Related]  

  • 84. DCE-MRI texture analysis with tumor subregion partitioning for predicting Ki-67 status of estrogen receptor-positive breast cancers.
    Fan M; Cheng H; Zhang P; Gao X; Zhang J; Shao G; Li L
    J Magn Reson Imaging; 2018 Jul; 48(1):237-247. PubMed ID: 29219225
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Deconvolution-based dynamic contrast-enhanced MR imaging of breast tumors: correlation of tumor blood flow with human epidermal growth factor receptor 2 status and clinicopathologic findings--preliminary results.
    Makkat S; Luypaert R; Stadnik T; Bourgain C; Sourbron S; Dujardin M; De Greve J; De Mey J
    Radiology; 2008 Nov; 249(2):471-82. PubMed ID: 18780825
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Improved diagnostic accuracy with multiparametric magnetic resonance imaging of the breast using dynamic contrast-enhanced magnetic resonance imaging, diffusion-weighted imaging, and 3-dimensional proton magnetic resonance spectroscopic imaging.
    Pinker K; Bogner W; Baltzer P; Gruber S; Bickel H; Brueck B; Trattnig S; Weber M; Dubsky P; Bago-Horvath Z; Bartsch R; Helbich TH
    Invest Radiol; 2014 Jun; 49(6):421-30. PubMed ID: 24566292
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Accuracy and precision of quantitative DCE-MRI parameters: How should one estimate contrast concentration?
    Wake N; Chandarana H; Rusinek H; Fujimoto K; Moy L; Sodickson DK; Kim SG
    Magn Reson Imaging; 2018 Oct; 52():16-23. PubMed ID: 29777820
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Influence of different post-contrast time points on dynamic contrast-enhanced (DCE) MRI T staging in breast cancer.
    Romeo V; Picariello V; Pignata A; Mancusi V; Stanzione A; Cuocolo R; Di Crescenzo R; Accurso A; Staibano S; Imbriaco M
    Eur J Radiol; 2020 Mar; 124():108819. PubMed ID: 31958631
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Dynamic contrast-enhanced and diffusion-weighted MRI of estrogen receptor-positive invasive breast cancers: Associations between quantitative MR parameters and Ki-67 proliferation status.
    Shin JK; Kim JY
    J Magn Reson Imaging; 2017 Jan; 45(1):94-102. PubMed ID: 27313102
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Dynamic contrast-enhanced magnetic resonance imaging measurements in renal cell carcinoma: effect of region of interest size and positioning on interobserver and intraobserver variability.
    Braunagel M; Radler E; Ingrisch M; Staehler M; Schmid-Tannwald C; Rist C; Nikolaou K; Reiser MF; Notohamiprodjo M
    Invest Radiol; 2015 Jan; 50(1):57-66. PubMed ID: 25260094
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Histogram analysis of quantitative parameters from synthetic MRI: Correlations with prognostic factors and molecular subtypes in invasive ductal breast cancer.
    Li Q; Xiao Q; Yang M; Chai Q; Huang Y; Wu PY; Niu Q; Gu Y
    Eur J Radiol; 2021 Jun; 139():109697. PubMed ID: 33857828
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Single bolus split dynamic MRI: Is the combination of high spatial and dual-echo high temporal resolution interleaved sequences useful in the differential diagnosis of breast masses?
    Grøvik E; Bjørnerud A; Kurz KD; Kingsrød M; Sandhaug M; Storås TH; Gjesdal KI
    J Magn Reson Imaging; 2015 Jul; 42(1):180-7. PubMed ID: 25211038
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Effect of Temporal Resolution on Diagnostic Performance of Dynamic Contrast-Enhanced Magnetic Resonance Imaging of the Prostate.
    Othman AE; Falkner F; Weiss J; Kruck S; Grimm R; Martirosian P; Nikolaou K; Notohamiprodjo M
    Invest Radiol; 2016 May; 51(5):290-6. PubMed ID: 26619282
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Background parenchymal enhancement and its effect on lesion detectability in ultrafast dynamic contrast-enhanced MRI.
    Honda M; Kataoka M; Iima M; Miyake KK; Ohashi A; Kishimoto AO; Ota R; Nickel MD; Toi M; Togashi K
    Eur J Radiol; 2020 Aug; 129():108984. PubMed ID: 32534350
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Comparison of gadoteric acid and gadobutrol for detection as well as morphologic and dynamic characterization of lesions on breast dynamic contrast-enhanced magnetic resonance imaging.
    Renz DM; Durmus T; Böttcher J; Taupitz M; Diekmann F; Huppertz A; Pfeil A; Maurer MH; Streitparth F; Bick U; Hamm B; Fallenberg EM
    Invest Radiol; 2014 Jul; 49(7):474-84. PubMed ID: 24637587
    [TBL] [Abstract][Full Text] [Related]  

  • 96. The diagnostic sensitivity of dynamic contrast-enhanced magnetic resonance imaging and breast-specific gamma imaging in women with calcified and non-calcified DCIS.
    Kim JS; Lee SM; Cha ES
    Acta Radiol; 2014 Jul; 55(6):668-75. PubMed ID: 24043881
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Automated characterization of breast lesions imaged with an ultrafast DCE-MR protocol.
    Platel B; Mus R; Welte T; Karssemeijer N; Mann R
    IEEE Trans Med Imaging; 2014 Feb; 33(2):225-32. PubMed ID: 24058020
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Relationship between kinetic parameters of ultrafast dynamic contrast-enhanced (DCE) MRI and tumor-infiltrating lymphocytes (TILs) in breast cancer.
    Yamaguchi K; Nakazono T; Egashira R; Fukui S; Imaizumi T; Maruyama K; Nickel D; Hamamoto T; Yamaguchi R; Irie H
    Jpn J Radiol; 2024 Aug; ():. PubMed ID: 39186213
    [TBL] [Abstract][Full Text] [Related]  

  • 99. The Accuracy of Breast MR Imaging for Measuring the Size of a Breast Cancer: Analysis of the Histopathologic Factors.
    Choi WJ; Cha JH; Kim HH; Shin HJ; Chae EY
    Clin Breast Cancer; 2016 Dec; 16(6):e145-e152. PubMed ID: 27566960
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Potential of Noncontrast Magnetic Resonance Imaging With Diffusion-Weighted Imaging in Characterization of Breast Lesions: Intraindividual Comparison With Dynamic Contrast-Enhanced Magnetic Resonance Imaging.
    Baltzer PAT; Bickel H; Spick C; Wengert G; Woitek R; Kapetas P; Clauser P; Helbich TH; Pinker K
    Invest Radiol; 2018 Apr; 53(4):229-235. PubMed ID: 29190227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.